Ping An Biomedical Co., Ltd. (PASW)
Hong Kong, HK
Ping An Biomedical Co., Ltd. delivers comprehensive supply chain management services tailored for the clothing sector. The company furnishes integrated solutions to its clients, covering a wide spectrum of offerings from initial yarn products and various textiles to fully manufactured garments. Its operations are organized into two primary divisions: Yarns and Finished Garments. Established in 2013 by Yuk Yin Li and Sek Yan Ko, the firm's main office is situated in Hong Kong.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.39% | +3.26% | +22.28% | +28.57% | -70.85% | -64.65% | -84.97% | -84.97% | -84.97% | -84.97% | -84.97% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Industrial - Distribution: +4.8%+6.1% ★
-
EPS growth Industrial - Distribution: +8.9%+100.0% ★
-
FCF margin FCF growth · Industrial - Distribution: +12.0%+17.0%
-
EBIT margin Industrial - Distribution: +5.8%+0.0%
-
ROIC Industrial - Distribution: +7.4%+0.7%
-
Share dilution Industrial - Distribution: +0.0%-100.0% ★
-
Debt / EBITDA Net debt/EBITDA · Industrial - Distribution: 0.84×22.84×
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Owner's Earnings history not available.
Ownership Overview
No beneficial ownership filings recorded.
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | XTX TOPCO LTD | 136.4K +113.3K (+491.1%) | 18.0K +6.4K (+55.5%) | 0.67% +0.553 pp | 0.00% +0.000 pp | USD0.19 -31.6% | 2 qtrs — |
| 2 | JANE STREET GROUP, LLC | 52.5K +52.5K (+100.0%) | 6.9K +6.9K (+100.0%) | 0.26% +0.256 pp | 0.00% +0.000 pp | USD0.13 +0.0% | 1 qtrs NEW |
| 3 | TWO SIGMA SECURITIES, LLC | 33.2K +33.2K (+100.0%) | 4.4K +4.4K (+100.0%) | 0.16% +0.162 pp | 0.00% +0.001 pp | USD0.13 +0.0% | 1 qtrs NEW |
| 4 | UBS GROUP AG | 16.2K +11.5K (+243.8%) | 2.1K -223.0 (-9.4%) | 0.08% +0.056 pp | 0.00% +0.000 pp | USD0.24 -45.8% | 3 qtrs — |
| 5 | CITADEL ADVISORS LLC | — -22.9K (-100.0%) | — -11.5K (-100.0%) | 0.00% -0.112 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-14 | Yang Hongli (HLY) | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-10-14 | Liu Xianzhi (XZL) | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-10-14 | Liu Pijun (PJL) | Director / Officer | — | — | Class A Ordinary Shares | 0 | 0.00 | — | 12,250,000 | I | ↗ |
| 2025-07-29 | Liu Qingxian | Director | — | — | Class A Ordinary Shares | 0 | 0.00 | — | 599,400 | I | ↗ |
| 2025-07-29 | Gao Jifeng | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2006-12-31 | SLINEY WILLIAM E | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 500 | — | ↗ |
| 2003-12-31 | SLINEY WILLIAM E | Director / Officer | — | D | PASW | 0 | 0.00 | — | 187,500 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hongli Yang | Chief Financial Officer | — | female |
| Pijun Liu | Chief Executive Officer & Executive Chairman | — | male |
| Sek Yan Ko | Co-Founder & GM | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PASW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
